Evidence map›Paper›PMID 34037774›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2021

Cell surface integrin α5ß1 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3.

Alina Starchenko, Ramona Graves-Deal, Douglas Brubaker, Cunxi Li, Yuping Yang, Bhuminder Singh, Robert J Coffey, Douglas A Lauffenburger

Open access · bronzeAbstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alina StarchenkoMassachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA.
Ramona Graves-DealVanderbilt University Medical Center, Department of Cell & Developmental Biology, Nashville, TN, USA.
Douglas BrubakerPurdue University, Department of Biomedical Engineering, West Lafayette, IN, USA.
Cunxi LiVanderbilt University Medical Center, Department of Cell & Developmental Biology, Nashville, TN, USA.
Yuping YangVanderbilt University Medical Center, Department of Cell & Developmental Biology, Nashville, TN, USA.
Bhuminder SinghVanderbilt University Medical Center, Department of Cell & Developmental Biology, Nashville, TN, USA.
Robert J CoffeyVanderbilt University Medical Center, Department of Cell & Developmental Biology, Nashville, TN, USA.
Douglas A LauffenburgerMassachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA.
Vanderbilt University Medical Center · USMassachusetts Institute of Technology · USPurdue University West Lafayette · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2019 to 2026
$19.6M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
NCATS NIH HHS KL2 TR002245NCI NIH HHS P50 CA236733NCI NIH HHS R35 CA197570NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

As a key process within the tissue microenvironment, integrin signaling can influence cell functional responses to growth factor stimuli. We show here that clustering of integrin α5ß1 at the plasma membrane of colorectal cancer-derived epithelial cells modulates their ability to respond to stimulation by receptor tyrosine kinase (RTK)-activating growth factors EGF, NRG and HGF, through GSK3-mediated suppression of Akt pathway. We observed that integrin α5ß1 is lost from the membrane of poorly organized human colorectal tumors and that treatment with the integrin-clustering antibody P4G11 is sufficient to induce polarity in a mouse tumor xenograft model. While adding RTK growth factors (EGF, NRG and HGF) to polarized colorectal cancer cells induced invasion and loss of monolayer formation in 2D and 3D, this pathological behavior could be blocked by P4G11. Phosphorylation of ErbB family members as well as MET following EGF, NRG and HGF treatment was diminished in cells pretreated with P4G11. Focusing on EGFR, we found that blockade of integrin α5ß1 increased EGFR phosphorylation. Since activity of multiple downstream kinase pathways were altered by these various treatments, we employed computational machine learning techniques to ascertain the most important effects. Partial least-squares discriminant analysis identified GSK3 as a major regulator of EGFR pathway activities influenced by integrin α5ß1. Moreover, we used partial correlation analysis to examine signaling pathway crosstalk downstream of EGF stimulation and found that integrin α5ß1 acts as a negative regulator of the AKT signaling cascade downstream of EGFR, with GSK3 acting as a key mediator. We experimentally validated these computational inferences by confirming that blockade of GSK3 activity is sufficient to induce loss of polarity and increase of oncogenic signaling in the colonic epithelial cells.

Indexed as

Colorectal NeoplasmsIntegrin alpha5beta1AnimalsCell MembraneCluster AnalysisEpidermal Growth FactorGlycogen Synthase Kinase 3HeterograftsHumansMicePhosphorylationReceptor Protein-Tyrosine KinasesSignal TransductionTumor MicroenvironmentEpidermal Growth FactorGlycogen Synthase Kinase 3Integrin alpha5beta1Receptor Protein-Tyrosine Kinasescell signalingEGFRextracellular matrixgrowth factorintegrinreceptorssystems biologytyrosine kinase

Identifiers

PMID34037774
PMCPMC8204629
OpenAlexW3164732875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.